EU Approves Oral Weight-Loss Pill Foundayo, Rival to Injectable GLP-1s

Regulators have approved Foundayo, an oral weight-loss and diabetes tablet that works like existing GLP-1 injections (Ozempic, Wegovy, Mounjaro). The pill offers a more convenient alternative to injections, potentially expanding the market. The approval marks a significant step in the competitive GLP-1 landscape, though pricing and reimbursement details remain unclear.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works